Breaking News Instant updates and real-time market news.

CVS

CVS Health

$69.92

0.39 (0.56%)

07:36
02/20/19
02/20
07:36
02/20/19
07:36

CVS Health sees FY19 consolidated revenue $249.86B-$254.29B, consensus $247.61B

Says on track to exceed near-term synergy target of $750M in 2020. Says challenges -- structural and CVS-specific in long-term care space, lower brand inflation, questions about rebates, ongoing pharmacy reimbursement pressures -- having disproportionate impact vs. prior years. Says Continuing to evaluate all assets and the roles they play in enabling core strategies of the new company. Sees FY19 Enterprise revenue $249.86B-$254.29B, Retail/LTC adjusted revenue $*5.25B-$86.79B, Pharmacy Services adjusted revenue $136.59B-$138.95B, Health Care Benefits adjusted revenue $67.68B-$68.71B. Sees FY19 net synergies $300M-$350M, incremental investment spending $325M-$350M, effective tax rate about 26%, gross CapEx $2.3B-$2.6B, cash flow from operations $9.8B-$10.3B. Comments taken from slides being presented on the Q4 earnings conference call.

  • 20

    Feb

  • 22

    Feb

  • 27

    Feb

CVS CVS Health
$69.92

0.39 (0.56%)

01/25/19
PIPR
01/25/19
NO CHANGE
PIPR
Report that CVS excluded Amgen's Aimovig 'greatly exaggerated,' says Piper
Piper Jaffray analyst Christopher Raymond kept an Overweight rating and $220 price target on Amgen (AMGN) following a Reuters report from earlier on Friday which stated that CVS (CVS) has excluded Amgen's Aimovig from its formulary. The analyst called the report "Friday afternoon clickbait" and noted that while CVS currently provides preferred status to Teva's (TEVA) Ajovy and Eli Lilly's (LLY) Emgality, this was made public in late 2018. In a check with management, Raymond found out the decision only encompasses about one-third of CVS network, that CVS is actively working to improve this access, and that 70% of commercial migraine patients have contracted access to Aimovig. Raymond concluded that this was "not something to worry about" in his view, and did not change his Q4, FY19, or FY20 estimates on Aimovig. In Friday trading, shares of Amgen were down just over 1% to $198.77.
01/28/19
CLVD
01/28/19
NO CHANGE
CLVD
CVS Health likely lost Coretrust contrac, says Cleveland Research
Cleveland Research said it is likely CVS Health lost the Coretrst contract to OptumRx, on top of the loss of BCBS of South Carolina to OptumRx.
01/31/19
MSCO
01/31/19
NO CHANGE
Target $391
MSCO
Overweight
Anthem price target raised to $391 from $372 at Morgan Stanley
Morgan Stanley analyst Zack Sopcak said Anthem's (ANTM) launch of IngenioRx three quarters early, giving it a presence in the 2020 selling season, leads him to see an increased likelihood of gaining share as compared to entry in the 2021 selling season when CVS Health (CVS) and Cigna (CI) would have more time for their marketing messages to mature post their respective mergers. While also noting that Anthem's 2019 guidance for EPS of $19+ came in well above estimates, Sopcak raised his price target on the stock to $391 from $372 and reiterated as a top pick with an Overweight rating.
02/07/19
MSCO
02/07/19
NO CHANGE
Target $100
MSCO
Overweight
CVS shares could rise 4%-9% on 'good enough' guidance, says Morgan Stanley
Morgan Stanley analyst Ricky Goldwasser noted that CVS Health will provide guidance on February 20 for the first time since completing the Aetna transaction and he puts 60% odds on initial FY19 EPS guidance of $7.00-$7.30. While such an outlook would be below the current consensus of $7.44, bears are concerned guidance could be below $7 and such an outlook would be seen as "good enough" to drive the stock up 4%-9%, Goldwasser tells investors. If initial 2019 EPS guidance is below $7.00, which is a scenario he gives a 30% probability, the stock could be down 11%. If the initial 2019 EPS guidance range has a midpoint above $7.40, which Goldwasser assigns only 10% odds of happening, the stock could be up 10%, the analyst said. He keeps an Overweight rating and $100 price target on CVS shares ahead of the company's December quarter earnings report.

TODAY'S FREE FLY STORIES

IHRT

iHeartMedia

$14.79

0.11 (0.75%)

08:53
09/19/19
09/19
08:53
09/19/19
08:53
Initiation
iHeartMedia initiated  »

B. Riley FBR starts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 23

    Sep

PODD

Insulet

$148.04

3 (2.07%)

08:50
09/19/19
09/19
08:50
09/19/19
08:50
Conference/Events
Insulet participates in a conference call with SVB Leerink »

Conference call with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMWYY

BMW

$0.00

(0.00%)

08:50
09/19/19
09/19
08:50
09/19/19
08:50
Periodicals
BMW to cut up to 6,000 jobs in Germany, Bloomberg reports »

BMW plans to cut up to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:50
09/19/19
09/19
08:50
09/19/19
08:50
General news
The 2k initial claims uptick to 208k »

The 2k initial claims…

08:50
09/19/19
09/19
08:50
09/19/19
08:50
General news
U.S. Q2 current account balance narrowed to -$128.2 B »

U.S. Q2 current account…

PPC

Pilgrim's Pride

$30.86

-0.39 (-1.25%)

08:49
09/19/19
09/19
08:49
09/19/19
08:49
Recommendations
Pilgrim's Pride analyst commentary  »

Pilgrim's Pride…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 13

    Nov

GIS

General Mills

$54.51

-0.52 (-0.94%)

08:48
09/19/19
09/19
08:48
09/19/19
08:48
Recommendations
General Mills analyst commentary  »

Operating gains at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 01

    Oct

NEOG

Neogen

$78.05

-0.71 (-0.90%)

08:48
09/19/19
09/19
08:48
09/19/19
08:48
Hot Stocks
Neogen partners with IGS to enhance Igenity Beef Profile »

Neogen has entered into a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 03

    Oct

  • 13

    Nov

PRSP

Perspecta

$26.02

0.015 (0.06%)

08:47
09/19/19
09/19
08:47
09/19/19
08:47
Hot Stocks
Perspecta Labs awarded $2.9M contract from CMG »

Perspecta announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INSP

Inspire Medical

$64.41

0.14 (0.22%)

08:46
09/19/19
09/19
08:46
09/19/19
08:46
Conference/Events
Inspire Medical participates in a conference call with SVB Leerink »

Conference call with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EWW

iShares MSCI Mexico

$43.37

-0.4 (-0.91%)

, CGC

Canopy Growth

$28.82

0.42 (1.48%)

08:45
09/19/19
09/19
08:45
09/19/19
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

EWW

iShares MSCI Mexico

$43.37

-0.4 (-0.91%)

CGC

Canopy Growth

$28.82

0.42 (1.48%)

FSLY

Fastly

$28.53

0.285 (1.01%)

INSG

Inseego

$4.98

0.04 (0.81%)

PAYS

Paysign

$10.67

-0.57 (-5.07%)

PD

PagerDuty

$30.41

-0.125 (-0.41%)

UBER

Uber

$34.24

-0.04 (-0.12%)

TELL

Tellurian

$8.34

0.01 (0.12%)

UPRO

Uproar Inc

$57.03

0.055 (0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

08:45
09/19/19
09/19
08:45
09/19/19
08:45
General news
U.S. Philly Fed index fell 4.8 points to 12.0 in September »

U.S. Philly Fed index…

RAMP

LiveRamp

$46.01

-0.4 (-0.86%)

08:44
09/19/19
09/19
08:44
09/19/19
08:44
Recommendations
LiveRamp analyst commentary  »

LiveRamp conference…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FANG

Diamondback Energy

$98.23

-2.14 (-2.13%)

08:42
09/19/19
09/19
08:42
09/19/19
08:42
Conference/Events
Diamondback Energy participates in a conference call with JPMorgan »

Conference call with CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

AYI

Acuity Brands

$134.10

-1.04 (-0.77%)

, ETN

Eaton

$84.98

-1.11 (-1.29%)

08:42
09/19/19
09/19
08:42
09/19/19
08:42
Recommendations
Acuity Brands, Eaton analyst commentary  »

Acuity competition to…

AYI

Acuity Brands

$134.10

-1.04 (-0.77%)

ETN

Eaton

$84.98

-1.11 (-1.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

NGVT

Ingevity

$87.30

-0.62 (-0.71%)

, GM

General Motors

$38.18

-0.1 (-0.26%)

08:42
09/19/19
09/19
08:42
09/19/19
08:42
Recommendations
Ingevity, General Motors analyst commentary  »

Ingevity fundamentals not…

NGVT

Ingevity

$87.30

-0.62 (-0.71%)

GM

General Motors

$38.18

-0.1 (-0.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

08:40
09/19/19
09/19
08:40
09/19/19
08:40
General news
FX Action: The dollar »

FX Action: The dollar was…

08:40
09/19/19
09/19
08:40
09/19/19
08:40
General news
U.S. initial jobless claims edged up 2k to 208k in the week ended September 14 »

U.S. initial jobless…

VEND

Generation NEXT Franchise Brands

$0.00

(0.00%)

08:39
09/19/19
09/19
08:39
09/19/19
08:39
Hot Stocks
Generation NEXT to launch Reis & Irvy loyalty program, app during 2H20 »

Generation Next…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRCO

Tribune Media

$46.66

(0.00%)

08:37
09/19/19
09/19
08:37
09/19/19
08:37
Hot Stocks
Breaking Hot Stocks news story on Tribune Media »

Tribune Media trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DRI

Darden

$127.40

1.31 (1.04%)

08:37
09/19/19
09/19
08:37
09/19/19
08:37
Hot Stocks
Darden sees low single digit inflation for beef, produce, chicken in Q2 »

For the second quarter,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

08:36
09/19/19
09/19
08:36
09/19/19
08:36
Conference/Events
SEC to hold a closed commission meeting »

Closed Commission Meeting…

VEND

Generation NEXT Franchise Brands

$0.00

(0.00%)

08:36
09/19/19
09/19
08:36
09/19/19
08:36
Earnings
Generation NEXT Franchise Brands sees FY20 revenue $30M-$40M »

Generation Next Franchise…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$243.43

-1.36 (-0.56%)

, AUDVF

Audi AG

$0.00

(0.00%)

08:36
09/19/19
09/19
08:36
09/19/19
08:36
Hot Stocks
Tesla earns first-ever safety award from IIHS for Model 3 »

Tesla's (TSLA) Model…

TSLA

Tesla

$243.43

-1.36 (-0.56%)

AUDVF

Audi AG

$0.00

(0.00%)

HYMTF

Hyundai Motor

$0.00

(0.00%)

GM

General Motors

$38.18

-0.1 (-0.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 23

    Sep

08:35
09/19/19
09/19
08:35
09/19/19
08:35
Conference/Events
Board of Governors of the Federal Reserve System to hold a meeting »

The Board of Governors of…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.